The NHS is expanding access to a prostate cancer drug in England, which is expected to save thousands of lives. The move is reportedly a significant expansion of research and treatment for prostate cancer, and may also involve the use of precision treatment to reduce radiotherapy doses. Thousands of men with prostate cancer are set to receive the life-extending drug as a result of this expansion.